Epstein-Barr virus antibodies in multiple sclerosis.

Area of Science:

• Immunology
• Virology
• Neurology

Background:

• Epstein-Barr virus (EBV) establishes a lifelong latent infection.
• Multiple sclerosis (MS) is a chronic neurological disease with suspected immune system involvement.

Purpose of the Study:

• To investigate the association between serum antibody titers to Epstein-Barr virus (EBV) and multiple sclerosis (MS).
• To explore potential immune system aberrations in MS patients related to EBV infection.

Main Methods:

• Serum samples were collected from 157 MS patients and 81 healthy controls.
• Antibody titers to EBV were quantified using serological assays.
• Prevalence of high titers and geometric mean titers were compared between groups.

Main Results:

• A significantly higher prevalence of high EBV antibody titers (≥1:160) was observed in MS patients (44.5%) compared to controls (28.9%).
• The geometric mean EBV antibody titer was significantly elevated in MS patients (107.0) versus controls (77.1).
• No correlation was found between EBV antibody titers and MS disease duration or activity.

Conclusions:

• These findings support the hypothesis that individuals with MS exhibit altered immune responses.
• Elevated EBV antibody titers in MS patients may indicate a role for EBV in the disease pathogenesis or reflect a broader immunological abnormality.